Overview

K-924 Phase III Confirmatory Study

Status:
Completed

Trial end date:
2020-11-21

Target enrollment:

Participant gender:

Summary

A multicenter, active-controlled, randomized, double-blind comparative study to compare the efficacy and safety of K-924 LD tablet or K-924 HD tablet to pitavastatin 2 mg or 4 mg in patienta with hypercholesterolemia.

Phase:

Phase 3

Details

Lead Sponsor:

Kowa Company, Ltd.

Treatments:

Pitavastatin